ACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors

December 20, 2023

https://www.globenewswire.com/news-release/2023/12/20/2799659/0/en/ACELYRIN-INC-Appoints-Lynn-Tetrault-to-Board-of-Directors.html

LOS ANGELES, Dec. 20, 2023 (GLOBE NEWSWIRE) — ACELYRIN, INC. (Nasdaq:SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced the appointment of Lynn Tetrault to its board of directors.

Read more at globenewswire.com

Related news for (SLRN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.